4
Changes in Ownership
InMed Pharmaceuticals Inc. Filed Acc 0001213900-24-020087
Options or other derivatives
- Sr. VP, Pre-Clinical Res/Dev disposed of 309 shares (code H)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 2024-03-04 | Other disposition · Employee Stock Option (Expiration) | −309 | 52,545 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…